In-vivo Deposition Measurement of Beclometasone and Formoterol After Inhalation of a Single Dose of the Combination BDP Plus Formoterol NEXT DPI in Healthy Volunteers, Asthmatic and COPD Patients.
Phase of Trial: Phase I/II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Chiesi Farmaceutici
- 13 Apr 2011 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 13 Apr 2011 Actual initiation date (Aug 2010 ) added as reported by ClinicalTrials.gov.
- 13 Apr 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.